HomeInvestors HealthEli Lilly, Novo stocks in focus as RFK Jr. leads HHS (NVO:NYSE) Eli Lilly, Novo stocks in focus as RFK Jr. leads HHS (NVO:NYSE) By BOMAR ENT. February 16, 2025 FacebookTwitterPinterestWhatsApp Andrew Harnik/Getty Images News Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) have found themselves in two contrasting positions as Robert F. Kennedy Jr., a leading critic of weight loss drugs, takes the helm of the Department of Health Source link Previous articleAre Our Predictions Already Wrong?Next articleTHE PATH TO SUCCESS IN TRADING latest articles explore more Controversial “Climate Risk Scores” Keep Rising—And It’s Making a Major Dent on Investor Profits in Major Markets Cryptocurrency for Beginners: Step-by-Step Guide to Crypto Trading, Wallet Security & Blockchain Basics to Avoid Common Scams, Protect Investments, and Understand Legal & Tax... Hands-On Smart Contract Development with Solidity and Ethereum: From Fundamentals to Deployment Tax Season 2026 Is Here: 8 Big Tax Changes to Know Before You File Value Investing: The Secret to Picking Stocks, Price-to-Earnings Ratios and Valuing a Stock to Build Your Passive Income Empire and Be Part of the... The Only Guide to a Winning Investment Strategy You’ll Ever Need: The Way Smart Money Invests Today LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
